Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × Carcinoma, Squamous Cell × Clear all

NCT07628634 2026-06-05

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

Phase EARLY_PHASE1 Recruiting

CNSDermatologicGenitourinaryLymphoidSarcoma

Adenocarcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Glioma, Leiomyosarcoma, Lymphoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Carcinoma, Ductal

NCT06782399 2026-05-18

SCC

Phase EARLY_PHASE1 Enrolling by invitation

Carcinoma, Squamous Cell

NCT06819228 2026-05-08

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

Phase EARLY_PHASE1 Recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Mouth Neoplasms, Tongue Neoplasms

NCT05678348 2025-08-17

Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase EARLY_PHASE1 Completed

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT01755650 2023-09-13

Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies

Phase EARLY_PHASE1 Terminated

Carcinoma, Squamous Cell

NCT04839731 2023-02-13

Combination 5-FU / Calcipotriene Cream for SCCIS/SCC

Phase EARLY_PHASE1 Unknown

Carcinoma, Squamous Cell

NCT02593929 2017-06-08

Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer

Phase EARLY_PHASE1 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms